[Retracted] Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study
Table 3
Association between measures of adiposity and testing positive for SARS-CoV-2 overall and stratified by older age.
Variable
Full population†
Under 65 years†‡ (range 50–64)
65 years of age or older† (range 65–84)
Total number tested for SARS-CoV-2, n (%)
9,386
2,872 (30.6)
6,514 (69.4)
Tested positive for SARS-CoV-2, n (%)
1,577 (16.8)
598 (20.8)
979 (15.0)
Demographics
Male
1.23 (1.12 to 1.34)
1.14 (0.98 to 1.32)
1.29 (1.14 to 1.46)
Race
White
Ref
Ref
Ref
Asian
1.60 (1.30 to 1.97)
1.79 (1.35 to 2.36)
1.56 (1.13 to 2.15)
Black
1.74 (1.44 to 2.10)
1.64 (1.28 to 2.10)
1.89 (1.43 to 2.51)
Mixed
1.01 (0.60 to 1.70)
0.63 (0.28 to 1.40)
1.82 (0.96 to 3.44)
Missing
1.25 (0.93 to 1.67)
1.34 (0.92 to 1.96)
1.30 (0.82 to 2.06)
Anthropometric measures
Body mass index categories (continuous)
1.06 (1.02 to 1.11)
1.09 (1.02 to 1.17)
1.05 (0.99 to 1.11)
Body mass index categories
Underweight/normal weight
Ref
Ref
Ref
Overweight
1.14 (1.01 to 1.28)
1.17 (0.98 to 1.39)
1.12 (0.96 to 1.31)
Obesity class I
1.12 (0.98 to 1.28)
1.10 (0.88 to 1.36)
1.13 (0.95 to 1.35)
Obesity class II
1.35 (1.13 to 1.61)
1.35 (1.03 to 1.78)
1.38 (1.10 to 1.74)
Obesity class III
1.15 (0.89 to 1.48)
1.61 (1.12 to 2.32)
0.99 (0.70 to 1.40)
HWC
1.06 (0.96 to 1.17)
0.93 (0.77 to 1.12)
1.12 (1.00 to 1.27)
Statistically significant ().†Estimates are adjusted for age at testing, race, education, body mass index categories, HWC, smoking status, alcohol use, whole organ transplant, inflammatory disease of the central nervous system, and liver disease. ‡9 excluded for missing alcohol information preventing convergence.
